The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia

NCT02300233 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia

Interventions

DRUG: Volanesorsen
DRUG: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.

Collaborators

[object Object]